Influenza Diagnostics Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Influenza Diagnostics Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx7.83%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Competitive Analysis of the Influenza Diagnostics Market:

The influenza diagnostic market is highly competitive and consolidated in nature due to the dominance of a few major players. The majority of players are focusing on adopting strategies such as new product launches, vertical collaboration, technological developments and discoveries, mergers and acquisitions, etc. 

Influenza Diagnostics Market News

  • February 2023 - Becton, Dickinson, and Company received FDA Emergency Use Authorization for Influenza A/B, COVID-19, RSV Combination Test:

BD, a leading company, received Emergency Use Authorization from US FDA for a new molecular diagnostic combination test. The test uses a single nasal swab to identify influenza and other combinations of viruses within two hours.

  • July 2022 - Thermo Fisher Scientific launched CE-IVD marked TaqPath respiratory viral select panel:

Thermo Fisher Scientific, the world's leading company in serving science announced the launch of the applied biosystem TaqPath respiratory vira; select panel. The molecular assay panel detects five common viruses causing the common cold, croup, bronchiolitis, influenza, and pneumonia. The panel provides results in three hours using accurate PCR technology.

  • June 2022 - Seegene got approval from the EU for Allplex respiratory panel assay:

Seegene IncSouth Korea’s leading molecular diagnostics company has obtained EU approval for Alllplex respiratory panel assay for SARS-Co-2, influenza A and B, etc which can assist small hospitals, and clinics for effective identification.

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
3M••• ••• ••• •••
Thermo Fisher Scientific Inc.••• ••• ••• •••
Abbott Laboratories Inc.••• ••• ••• •••
Meridian Bioscience Inc.••• ••• ••• •••
Becton••• ••• ••• •••
Dickinson••• ••• ••• •••
and Company (Bd)••• ••• ••• •••
F. Hoffmann-LA Roche AG••• ••• ••• •••
Quidel Corporation••• ••• ••• •••
DiaSorin Molecular••• ••• ••• •••
SA Scientific••• ••• ••• •••
Sekisui Diagnostics••• ••• ••• •••
Hologic Inc.••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

As per Cognitive Market Research's latest published report, the Global Influenza Diagnostics market size was $843.8 Million in 2022 and it is forecasted to reach $1,425.2 Million by 2030. Influenza Diagnostics Industry's Compound Annual Growth Rate will be 7.83% from 2023 to 2030.

Introduction of Influenza Diagnostics

Influenza is a type of viral infection that causes serious morbidity and mortality all over the world. Influenzas are of three types: Type A, Type B, and Type C. Influenza A is the most responsible for pandemics. Tests for diagnosis of influenza viruses in the respiratory system are molecular assays, RT-PCR tests, RIDT, and antigen detection tests. Influenza is a very contagious disease coupled with symptoms like fever, cough, myalgias, chills or sweats, etc. Rising demand for rapid diagnostic tests, increasing prevalence of influenza, and technological advancements are fueling the growth of the influenza diagnostic market.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Influenza Diagnostics Market Analysis is witnessing significant growth in the near future.

In 2023, the Test Kits segment accounted for a notable share of the Influenza Diagnostics Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

The global market value of Influenza diagnostics was USD 843.8 Million in the year 2022 and it is expected to grow up to USD 1,425.2 Million in 2030.
The market for influenza diagnostics is expected to grow with a CAGR of 7.83%.
Rising prevalence of influenza, rising awareness about the early diagnosis and prevention of influenza, growing research in influenza diagnostic technologies, rising government initiatives, growing geriatric population are the main driving factors of the influenza diagnostics market.
Some of the major players in the influenza diagnostics market are 3M, Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson, and Company, F. Hoffmann-LA Roche AG, Quidel Corporation, DiaSorin Molecular, SA Scientific, Sekisui Diagnostics, Hologic, Inc.
Diagnostics tests for influenza are RT-PCR, viral culture, rapid antigen testing, serology, rapid molecular assays and immunofluorescence assays.

★ Reviews

Rate this report

Influenza Diagnostics Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
License Edition

Product Test Kits, Reagents, Instruments
Test Type RIDT, RT-PCR, Cell Culture
End-use Hospitals, Laboratories, POCT
List of Competitors 3M, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Meridian Bioscience Inc., Becton, Dickinson, and Company (Bd), F. Hoffmann-LA Roche AG, Quidel Corporation, DiaSorin Molecular, SA Scientific, Sekisui Diagnostics, Hologic Inc.

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Influenza Diagnostics Market Analysis by Key Players
    • 1.1.2 Global Influenza Diagnostics Market Volume and Share by Key Players
    • 1.1.3 Top Players Ranking 2024
    • 1.1.4 New Product Launch Analysis
    • 1.1.5 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 3M
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Thermo Fisher Scientific Inc.
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 Abbott Laboratories Inc.
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 Meridian Bioscience Inc.
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 Becton
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 Dickinson
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.7 and Company (Bd)
      • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.7.2 Business Overview
      • 1.2.7.3 Financials (Subject to data availability)
      • 1.2.7.4 R&D Investment (Subject to data availability)
      • 1.2.7.5 Product Types Specification
      • 1.2.7.6 Business Strategy
      • 1.2.7.7 Recent Developments
      • 1.2.7.8 Management Change
      • 1.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.8 F. Hoffmann-LA Roche AG
      • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.8.2 Business Overview
      • 1.2.8.3 Financials (Subject to data availability)
      • 1.2.8.4 R&D Investment (Subject to data availability)
      • 1.2.8.5 Product Types Specification
      • 1.2.8.6 Business Strategy
      • 1.2.8.7 Recent Developments
      • 1.2.8.8 Management Change
      • 1.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.9 Quidel Corporation
      • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.9.2 Business Overview
      • 1.2.9.3 Financials (Subject to data availability)
      • 1.2.9.4 R&D Investment (Subject to data availability)
      • 1.2.9.5 Product Types Specification
      • 1.2.9.6 Business Strategy
      • 1.2.9.7 Recent Developments
      • 1.2.9.8 Management Change
      • 1.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.10 DiaSorin Molecular
      • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.10.2 Business Overview
      • 1.2.10.3 Financials (Subject to data availability)
      • 1.2.10.4 R&D Investment (Subject to data availability)
      • 1.2.10.5 Product Types Specification
      • 1.2.10.6 Business Strategy
      • 1.2.10.7 Recent Developments
      • 1.2.10.8 Management Change
      • 1.2.10.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.11 SA Scientific
      • 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.11.2 Business Overview
      • 1.2.11.3 Financials (Subject to data availability)
      • 1.2.11.4 R&D Investment (Subject to data availability)
      • 1.2.11.5 Product Types Specification
      • 1.2.11.6 Business Strategy
      • 1.2.11.7 Recent Developments
      • 1.2.11.8 Management Change
      • 1.2.11.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.12 Sekisui Diagnostics
      • 1.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.12.2 Business Overview
      • 1.2.12.3 Financials (Subject to data availability)
      • 1.2.12.4 R&D Investment (Subject to data availability)
      • 1.2.12.5 Product Types Specification
      • 1.2.12.6 Business Strategy
      • 1.2.12.7 Recent Developments
      • 1.2.12.8 Management Change
      • 1.2.12.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.13 Hologic Inc.
      • 1.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.13.2 Business Overview
      • 1.2.13.3 Financials (Subject to data availability)
      • 1.2.13.4 R&D Investment (Subject to data availability)
      • 1.2.13.5 Product Types Specification
      • 1.2.13.6 Business Strategy
      • 1.2.13.7 Recent Developments
      • 1.2.13.8 Management Change
      • 1.2.13.9 S.W.O.T Analysis

  • 2.1 Global Influenza Diagnostics Revenue Market Size, Trend Analysis 2022 - 2034
  • 2.2 Global Influenza Diagnostics Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    2.3 Global Influenza Diagnostics Market Analysis By Regions 2022 - 2034
    • 2.3.1 Global Influenza Diagnostics Revenue Market Size By Region
    • 2.3.2 Global Influenza Diagnostics Volume Market Sales By Region
  • 2.4 Global Influenza Diagnostics Market Size By Product 2022 - 2034
    • 2.4.1 Test Kits Market Size
    • 2.4.2 Reagents Market Size
    • 2.4.3 Instruments Market Size
  • 2.5 Global Influenza Diagnostics Volume Market Sales By Product 2022 - 2034
    • 2.5.1 Test Kits Sales Volume
    • 2.5.2 Reagents Sales Volume
    • 2.5.3 Instruments Sales Volume
  • 2.6 Global Influenza Diagnostics Market Size By Test Type 2022 - 2034
    • 2.6.1 RIDT Market Size
    • 2.6.2 RT-PCR Market Size
    • 2.6.3 Cell Culture Market Size
  • 2.7 Global Influenza Diagnostics Volume Market Sales By Test Type 2022 - 2034
    • 2.7.1 RIDT Sales Volume
    • 2.7.2 RT-PCR Sales Volume
    • 2.7.3 Cell Culture Sales Volume
  • 2.8 Global Influenza Diagnostics Market Size By End-use 2022 - 2034
    • 2.8.1 Hospitals Market Size
    • 2.8.2 Laboratories Market Size
    • 2.8.3 POCT Market Size
  • 2.9 Global Influenza Diagnostics Volume Market Sales By End-use 2022 - 2034
    • 2.9.1 Hospitals Sales Volume
    • 2.9.2 Laboratories Sales Volume
    • 2.9.3 POCT Sales Volume
  • 2.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    2.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 2.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 2.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 2.11.3 Global Market Revenue Split By Product
    • 2.11.4 Global Volume Market Split By Product
    • 2.11.5 Global Market Revenue Split By Test Type
    • 2.11.6 Global Volume Market Split By Test Type
    • 2.11.7 Global Market Revenue Split By End-use
    • 2.11.8 Global Volume Market Split By End-use

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      2.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 3.1 North America Influenza Diagnostics Market Outlook
    • 3.1.1 North America Influenza Diagnostics Market Size 2022 - 2034
    • 3.1.2 North America Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 3.1.3 North America Influenza Diagnostics Market Size By Country 2022 - 2034
    • 3.1.4 North America Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 3.1.5 North America Influenza Diagnostics Market Size by Product 2022 - 2034
      • 3.1.5.1 North America Test Kits Market Size
      • 3.1.5.2 North America Reagents Market Size
      • 3.1.5.3 North America Instruments Market Size
    • 3.1.6 North America Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 3.1.6.1 North America Test Kits Sales Volume
      • 3.1.6.2 North America Reagents Sales Volume
      • 3.1.6.3 North America Instruments Sales Volume
    • 3.1.7 North America Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 3.1.7.1 North America RIDT Market Size
      • 3.1.7.2 North America RT-PCR Market Size
      • 3.1.7.3 North America Cell Culture Market Size
    • 3.1.8 North America Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 3.1.8.1 North America RIDT Sales Volume
      • 3.1.8.2 North America RT-PCR Sales Volume
      • 3.1.8.3 North America Cell Culture Sales Volume
    • 3.1.9 North America Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 3.1.9.1 North America Hospitals Market Size
      • 3.1.9.2 North America Laboratories Market Size
      • 3.1.9.3 North America POCT Market Size
    • 3.1.10 North America Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 3.1.10.1 North America Hospitals Sales Volume
      • 3.1.10.2 North America Laboratories Sales Volume
      • 3.1.10.3 North America POCT Sales Volume

  • 4.1 Europe Influenza Diagnostics Market Outlook
    • 4.1.1 Europe Influenza Diagnostics Market Size 2022 - 2034
    • 4.1.2 Europe Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 4.1.3 Europe Influenza Diagnostics Market Size By Country 2022 - 2034
    • 4.1.4 Europe Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 4.1.5 Europe Influenza Diagnostics Market Size by Product 2022 - 2034
      • 4.1.5.1 Europe Test Kits Market Size
      • 4.1.5.2 Europe Reagents Market Size
      • 4.1.5.3 Europe Instruments Market Size
    • 4.1.6 Europe Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 4.1.6.1 Europe Test Kits Sales Volume
      • 4.1.6.2 Europe Reagents Sales Volume
      • 4.1.6.3 Europe Instruments Sales Volume
    • 4.1.7 Europe Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 4.1.7.1 Europe RIDT Market Size
      • 4.1.7.2 Europe RT-PCR Market Size
      • 4.1.7.3 Europe Cell Culture Market Size
    • 4.1.8 Europe Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 4.1.8.1 Europe RIDT Sales Volume
      • 4.1.8.2 Europe RT-PCR Sales Volume
      • 4.1.8.3 Europe Cell Culture Sales Volume
    • 4.1.9 Europe Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 4.1.9.1 Europe Hospitals Market Size
      • 4.1.9.2 Europe Laboratories Market Size
      • 4.1.9.3 Europe POCT Market Size
    • 4.1.10 Europe Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 4.1.10.1 Europe Hospitals Sales Volume
      • 4.1.10.2 Europe Laboratories Sales Volume
      • 4.1.10.3 Europe POCT Sales Volume

  • 5.1 Asia Pacific Influenza Diagnostics Market Outlook
    • 5.1.1 Asia Pacific Influenza Diagnostics Market Size 2022 - 2034
    • 5.1.2 Asia Pacific Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 5.1.3 Asia Pacific Influenza Diagnostics Market Size By Country 2022 - 2034
    • 5.1.4 Asia Pacific Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Asia Pacific Influenza Diagnostics Market Size by Product 2022 - 2034
      • 5.1.5.1 Asia Pacific Test Kits Market Size
      • 5.1.5.2 Asia Pacific Reagents Market Size
      • 5.1.5.3 Asia Pacific Instruments Market Size
    • 5.1.6 Asia Pacific Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 5.1.6.1 Asia Pacific Test Kits Sales Volume
      • 5.1.6.2 Asia Pacific Reagents Sales Volume
      • 5.1.6.3 Asia Pacific Instruments Sales Volume
    • 5.1.7 Asia Pacific Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 5.1.7.1 Asia Pacific RIDT Market Size
      • 5.1.7.2 Asia Pacific RT-PCR Market Size
      • 5.1.7.3 Asia Pacific Cell Culture Market Size
    • 5.1.8 Asia Pacific Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 5.1.8.1 Asia Pacific RIDT Sales Volume
      • 5.1.8.2 Asia Pacific RT-PCR Sales Volume
      • 5.1.8.3 Asia Pacific Cell Culture Sales Volume
    • 5.1.9 Asia Pacific Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 5.1.9.1 Asia Pacific Hospitals Market Size
      • 5.1.9.2 Asia Pacific Laboratories Market Size
      • 5.1.9.3 Asia Pacific POCT Market Size
    • 5.1.10 Asia Pacific Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 5.1.10.1 Asia Pacific Hospitals Sales Volume
      • 5.1.10.2 Asia Pacific Laboratories Sales Volume
      • 5.1.10.3 Asia Pacific POCT Sales Volume

  • 6.1 South America Influenza Diagnostics Market Outlook
    • 6.1.1 South America Influenza Diagnostics Market Size 2022 - 2034
    • 6.1.2 South America Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 6.1.3 South America Influenza Diagnostics Market Size By Country 2022 - 2034
    • 6.1.4 South America Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 6.1.5 South America Influenza Diagnostics Market Size by Product 2022 - 2034
      • 6.1.5.1 South America Test Kits Market Size
      • 6.1.5.2 South America Reagents Market Size
      • 6.1.5.3 South America Instruments Market Size
    • 6.1.6 South America Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 6.1.6.1 South America Test Kits Sales Volume
      • 6.1.6.2 South America Reagents Sales Volume
      • 6.1.6.3 South America Instruments Sales Volume
    • 6.1.7 South America Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 6.1.7.1 South America RIDT Market Size
      • 6.1.7.2 South America RT-PCR Market Size
      • 6.1.7.3 South America Cell Culture Market Size
    • 6.1.8 South America Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 6.1.8.1 South America RIDT Sales Volume
      • 6.1.8.2 South America RT-PCR Sales Volume
      • 6.1.8.3 South America Cell Culture Sales Volume
    • 6.1.9 South America Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 6.1.9.1 South America Hospitals Market Size
      • 6.1.9.2 South America Laboratories Market Size
      • 6.1.9.3 South America POCT Market Size
    • 6.1.10 South America Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 6.1.10.1 South America Hospitals Sales Volume
      • 6.1.10.2 South America Laboratories Sales Volume
      • 6.1.10.3 South America POCT Sales Volume

  • 7.1 Middle East Influenza Diagnostics Market Outlook
    • 7.1.1 Middle East Influenza Diagnostics Market Size 2022 - 2034
    • 7.1.2 Middle East Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 7.1.3 Middle East Influenza Diagnostics Market Size By Country 2022 - 2034
    • 7.1.4 Middle East Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 7.1.5 Middle East Influenza Diagnostics Market Size by Product 2022 - 2034
      • 7.1.5.1 Middle East Test Kits Market Size
      • 7.1.5.2 Middle East Reagents Market Size
      • 7.1.5.3 Middle East Instruments Market Size
    • 7.1.6 Middle East Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 7.1.6.1 Middle East Test Kits Sales Volume
      • 7.1.6.2 Middle East Reagents Sales Volume
      • 7.1.6.3 Middle East Instruments Sales Volume
    • 7.1.7 Middle East Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 7.1.7.1 Middle East RIDT Market Size
      • 7.1.7.2 Middle East RT-PCR Market Size
      • 7.1.7.3 Middle East Cell Culture Market Size
    • 7.1.8 Middle East Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 7.1.8.1 Middle East RIDT Sales Volume
      • 7.1.8.2 Middle East RT-PCR Sales Volume
      • 7.1.8.3 Middle East Cell Culture Sales Volume
    • 7.1.9 Middle East Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 7.1.9.1 Middle East Hospitals Market Size
      • 7.1.9.2 Middle East Laboratories Market Size
      • 7.1.9.3 Middle East POCT Market Size
    • 7.1.10 Middle East Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 7.1.10.1 Middle East Hospitals Sales Volume
      • 7.1.10.2 Middle East Laboratories Sales Volume
      • 7.1.10.3 Middle East POCT Sales Volume

  • 8.1 Africa Influenza Diagnostics Market Outlook
    • 8.1.1 Africa Influenza Diagnostics Market Size 2022 - 2034
    • 8.1.2 Africa Influenza Diagnostics Volume Market Sales 2022 - 2034
    • 8.1.3 Africa Influenza Diagnostics Market Size By Country 2022 - 2034
    • 8.1.4 Africa Influenza Diagnostics Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Africa Influenza Diagnostics Market Size by Product 2022 - 2034
      • 8.1.5.1 Africa Test Kits Market Size
      • 8.1.5.2 Africa Reagents Market Size
      • 8.1.5.3 Africa Instruments Market Size
    • 8.1.6 Africa Influenza Diagnostics Volume Market Sales by Product 2022 - 2034
      • 8.1.6.1 Africa Test Kits Sales Volume
      • 8.1.6.2 Africa Reagents Sales Volume
      • 8.1.6.3 Africa Instruments Sales Volume
    • 8.1.7 Africa Influenza Diagnostics Market Size by Test Type 2022 - 2034
      • 8.1.7.1 Africa RIDT Market Size
      • 8.1.7.2 Africa RT-PCR Market Size
      • 8.1.7.3 Africa Cell Culture Market Size
    • 8.1.8 Africa Influenza Diagnostics Volume Market Sales by Test Type 2022 - 2034
      • 8.1.8.1 Africa RIDT Sales Volume
      • 8.1.8.2 Africa RT-PCR Sales Volume
      • 8.1.8.3 Africa Cell Culture Sales Volume
    • 8.1.9 Africa Influenza Diagnostics Market Size by End-use 2022 - 2034
      • 8.1.9.1 Africa Hospitals Market Size
      • 8.1.9.2 Africa Laboratories Market Size
      • 8.1.9.3 Africa POCT Market Size
    • 8.1.10 Africa Influenza Diagnostics Volume Market Sales by End-use 2022 - 2034
      • 8.1.10.1 Africa Hospitals Sales Volume
      • 8.1.10.2 Africa Laboratories Sales Volume
      • 8.1.10.3 Africa POCT Sales Volume

  • 9.1 Market Drivers
  • 9.2 Market Restraints
  • 9.3 Market Trends
  • 9.4 Market Opportunity
  • 9.5 Technological Road Map (Subject to Data Availability)
  • 9.6 Product Life Cycle (Subject to Data Availability)
  • 9.7 Customer and Buyer Behavior Analysis
    • 9.7.1 Consumer Demographics and Target Audience Assessment
    • 9.7.2 Consumer Purchase Behavior and Demand Assessment
    • 9.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 9.7.4 Digital Engagement, Customer Experience & Relationship Analysis
    • 9.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 9.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 9.7.7 Customer Buying Behavior & Purchase Decision Analysis
    • 9.7.8 Customer Expectations & Service Experience Evaluation
    • 9.7.9 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 9.7.10 Customer Retention & Loyalty Strategy Assessment
    • 9.7.11 Pricing, Affordability & Value Perception Analysis
    • 9.7.12 Customer Segmentation & Demand Pattern Analysis
    • 9.7.13 Relationship Management & Strategic Partnership Trends
  • 9.8 Market Attractiveness Analysis
  • 9.9 PESTEL Analysis
    • 9.9.1 Political Factors
    • 9.9.2 Economic Factors
    • 9.9.3 Social Factors
    • 9.9.4 Technological Factors
    • 9.9.5 Legal Factors
    • 9.9.6 Environmental Factors
  • 9.10 Industrial Chain Analysis (Subject to Data Availability)
    • 9.10.1 Industry Chain Analysis
    • 9.10.2 Manufacturing Cost Analysis
    • 9.10.3 Supply Side Analysis
      • 9.10.3.1 Raw Material Analysis
      • 9.10.3.2 Raw Material Procurement Analysis
      • 9.10.3.3 Raw Material Price Trend Analysis
  • 9.11 Porter’s Five Forces Analysis
    • 9.11.1 Bargaining Power of Suppliers
    • 9.11.2 Bargaining Power of Buyers
    • 9.11.3 Threat of New Entrants
    • 9.11.4 Threat of Substitutes
    • 9.11.5 Degree of Competition
  • 9.12 Patent Analysis (Subject to Data Availability)
  • 9.13 ESG Analysis
  • 9.14 Geopolitical Outlook
    • 9.14.1 Global Power Realignment & Strategic Alliances
    • 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 9.14.3 International Trade Relations & Market Access Environment
    • 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 9.14.6 Technology Sovereignty & Digital Geopolitics
    • 9.14.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    9.15 AI & Market Transformation
    • 9.15.1 Competitive Landscape Disruption & Strategic Shifts
    • 9.15.2 AI-Driven Transformation of Industry Value Chain
    • 9.15.3 Evolution of Business Models & Revenue Streams
    • 9.15.4 Operational Efficiency & Cost Structure Transformation
    • 9.15.5 AI-Driven Product, Service & Innovation Transformation
    • 9.15.6 Customer Behavior, AI Adoption & Future Market Evolution
    • 9.15.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 10.1 Test Kits
    • 10.1.1 Global Influenza Diagnostics Revenue Market Size and Share by Test Kits 2022 - 2034
    • 10.1.2 Global Influenza Diagnostics Volume Market Sales by Test Kits 2022 - 2034
  • 10.2 Reagents
    • 10.2.1 Global Influenza Diagnostics Revenue Market Size and Share by Reagents 2022 - 2034
    • 10.2.2 Global Influenza Diagnostics Volume Market Sales by Reagents 2022 - 2034
  • 10.3 Instruments
    • 10.3.1 Global Influenza Diagnostics Revenue Market Size and Share by Instruments 2022 - 2034
    • 10.3.2 Global Influenza Diagnostics Volume Market Sales by Instruments 2022 - 2034

  • 11.1 RIDT
    • 11.1.1 Global Influenza Diagnostics Revenue Market Size and Share by RIDT 2022 - 2034
    • 11.1.2 Global Influenza Diagnostics Volume Market Sales by RIDT 2022 - 2034
  • 11.2 RT-PCR
    • 11.2.1 Global Influenza Diagnostics Revenue Market Size and Share by RT-PCR 2022 - 2034
    • 11.2.2 Global Influenza Diagnostics Volume Market Sales by RT-PCR 2022 - 2034
  • 11.3 Cell Culture
    • 11.3.1 Global Influenza Diagnostics Revenue Market Size and Share by Cell Culture 2022 - 2034
    • 11.3.2 Global Influenza Diagnostics Volume Market Sales by Cell Culture 2022 - 2034

  • 12.1 Hospitals
    • 12.1.1 Global Influenza Diagnostics Revenue Market Size and Share by Hospitals 2022 - 2034
    • 12.1.2 Global Influenza Diagnostics Volume Market Sales by Hospitals 2022 - 2034
  • 12.2 Laboratories
    • 12.2.1 Global Influenza Diagnostics Revenue Market Size and Share by Laboratories 2022 - 2034
    • 12.2.2 Global Influenza Diagnostics Volume Market Sales by Laboratories 2022 - 2034
  • 12.3 POCT
    • 12.3.1 Global Influenza Diagnostics Revenue Market Size and Share by POCT 2022 - 2034
    • 12.3.2 Global Influenza Diagnostics Volume Market Sales by POCT 2022 - 2034

  • 13.1 Global Influenza Diagnostics Market Export Data (2022-2025)
  • 13.2 Global Influenza Diagnostics Market Import Data by Region (2022-2025)
  • 13.3 Global Influenza Diagnostics Market Export Data by Region (2022-2025)
  • 13.4 North America Influenza Diagnostics Market Import Data by Country (2019-2023)
  • 13.5 North America Influenza Diagnostics Market Export Data by Country (2019-2023)
  • 13.6 Europe Influenza Diagnostics Market Import Data by Country (2019-2023)
  • 13.7 Europe Influenza Diagnostics Market Export Data by Country (2019-2023)
  • 13.8 Asia Pacific Influenza Diagnostics Market Import Data by Country (2019-2023)
  • 13.9 Asia Pacific Influenza Diagnostics Market Export Data by Country (2019-2023)
  • 13.10 South America Influenza Diagnostics Market Import Data by Country (2019-2023)
  • 13.11 South America Influenza Diagnostics Market Export Data by Country (2019-2023)
  • 13.12 Middle East and Africa Influenza Diagnostics Market Import Data by Country (2019-2023)
  • 13.13 Middle East and Africa Influenza Diagnostics Market Export Data by Country (2019-2023)

  • 15.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    15.2 Analyst Point of View
  • 15.3 Assumptions and Acronyms

  • 16.1 Primary Data Collection
    • 16.1.1 Steps for Primary Data Collection
      • 16.1.1.1 Identification of KOL
    • 16.1.2 Backward Integration
    • 16.1.3 Forward Integration
    • 16.1.4 How Primary Research Help Us
    • 16.1.5 Modes of Primary Research
  • 16.2 Secondary Research
    • 16.2.1 How Secondary Research Help Us
    • 16.2.2 Sources of Secondary Research
  • 16.3 Data Validation
    • 16.3.1 Data Triangulation
    • 16.3.2 Top Down & Bottom Up Approach
    • 16.3.3 Cross check KOL Responses with Secondary Data
  • 16.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Influenza Diagnostics Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 13+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Influenza Diagnostics Market

Sources from Medical Devices & Consumables Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Influenza Diagnostics Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the influenza diagnostics market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.